I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn’t touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

| More on:
Caution, careful

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Though I am a big fan of stocks, on the whole, there are many individual stocks I wouldn’t touch with a 60-foot pole. Examples include bankruptcy cases, Russian stocks, and cannabis stocks. It’s not that there aren’t good opportunities in these sectors — there are — it’s just that the quality of the companies in them is so low on average that sifting through the dirt to find a diamond isn’t worth it. In this article, I will explore one TSX stock I wouldn’t touch with a 10- or even 60-foot pole.

Canopy Growth

Canopy Growth (TSX:WEED) is a Canadian cannabis company. It sells marijuana, hashish, edibles, and related products. There was a time when this company was one of the hottest things in town. In the lead-up to legalization in 2018, the company’s stock rallied to incredible highs. However, after legalization hit, it came out that the company was still losing money despite the revenue growth that legalization brought with it. Its stock started crashing then and has been in a secular downtrend ever since then.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.ca

No growth

There was a time when Canopy Growth was considered a growth stock. It’s in the company’s name, after all. So, it shouldn’t be surprising that the company did some growing in the old days. However, the growth is no longer in the picture. Because it had to wind down some money-losing business units a few years ago, Canopy’s revenue growth decelerated. In its most recent quarter, it delivered the following:

  • $121 million in revenue, up 2.1% year over year
  • $5.9 million in gross profit, improved from a loss in the year-ago quarter
  • A -$91 million operating loss, improved from $1.8 billion
  • A $41 million net loss
  • -$0.07 in diluted earnings per share (EPS), improved from -$5.24.

As you can see, there was hardly any revenue growth, and all of the earnings figures were negative. On the bright side, the losses narrowed as a percentage of revenue. That doesn’t change the fact that Canopy is rapidly burning through its cash pile, though. In 2018, it got a $5 billion cash infusion from Constellation Brands; as of the last quarter, it was down to $577 million. If it keeps losing money at this rate, then Canopy will eventually run out of balance sheet cash as well. Who knows what that could lead to?

Why Canopy’s earnings are negative

The main reason why Canopy keeps losing money is because it spent untold millions of dollars buying up competitors back in 2018, only for them to prove long-term unprofitable. Despite their lack of profits, these acquired companies nevertheless cost money to run. So, Canopy kept on incurring huge losses just to keep them going. Yet it was selling a commodity (cannabis) that didn’t have very high profit margins. So, it just kept on losing money year after year. This trend continues to this day.

Weed stock: The Foolish takeaway

I suppose it’s possible that Canopy could right its ship someday, but I wouldn’t bet on it. It’s losing money and running out of cash at the same time and is no longer able to attract multi-billion-dollar funding rounds from larger companies. I wouldn’t touch it with a 60-foot pole.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »